COVID-19
COVID-19 Vaccine Trial for Immunocompromised Populations Reveals Optimized Schedules for Enhanced Immunity
Researchers at the Kids Research Institute in Australia have published a new report on a multi-site, adaptive platform trial designed to assess the effectiveness of different booster vaccination schedules in the Australian immunocompromised population against COVID-19 caused by SARS-CoV-2 and its variants. The trial, titled "Bringing optimised coronavirus disease